University at Buffalo receives $7.6 million for HIV, AIDS research

BUFFALO, N.Y. The National Institute of Allergy and Infectious Diseases has awarded the University at Buffalo’s School of Pharmacy $7.6 million to research HIV and AIDS infection rates in global communities, test quality control analysis of HIV and AIDS treatment clinical trials and conduct other HIV/AIDS-related research, the school has said.

The award helps set up a Clinical Pharmacology Quality Assurance program. Monies will also support a new laboratory in the UB Pharmacotherapy Research Center on the UB Amherst campus, as well as a lab at the Translational Pharmacology Research Core in the downtown Buffalo Bioinformatics and Life Sciences building.

UB has named professor and clinical trials dean Gene Morse principal investigator.

“This international contract initiative with National Institutes of Health is another positive outcome of the close collaboration between the CoE and the School of Pharmacy,” Bruce Holm, senior vice provost and executive director of the CoE, told a reporter. “Morse’s program offers great opportunity for further expansion of our viral disease efforts at UB.”